DTIL

PRECISION BIOSCIENCES INC

DTIL·74019P207·US·Common Stock·Healthcare - Biotechnology-13D/G

DTIL (PRECISION BIOSCIENCES INC) is held by 51 institutional investors as of Q1 2026. Largest holders: Aberdeen Group plc ($12.3M), DRIEHAUS CAPITAL MANAGEMENT LLC ($5.5M), VANGUARD CAPITAL MANAGEMENT LLC ($5M). Net institutional sentiment: Bullish.

51
Holders
Avg rating(11 Elite)
$38.7M
Total Value
71% (56)
Fund Consensus
34 buying - 14 selling
DTILSmart Money Verdict
View all
Held by 51 funds
11 elite
Who's Trading
ActivistEAEmpery Asset Management, LP7.6%Apr 15, 2026
InsiderAMAmoroso MichaelSell $79KFeb 18, 2026
InsiderKAKelly John AlexanderSell $31KFeb 18, 2026
InsiderSJSMITH J. JEFFERSONSell $19KFeb 18, 2026
InsiderSDScimeca DarioSell $19KFeb 18, 2026
ActivistTATANG CAPITAL MANAGEMENT, LLC0.0%Feb 17, 2026
ActivistLYLynx1 Capital Management LP4.1%Feb 17, 2026
ActivistBLBleichroeder LP8.2%Feb 13, 2026
ActivistOAOctagon Capital Advisors LP10.0%Feb 10, 2026
ActivistAberdeen Group plcAberdeen Group plc8.9%Jan 27, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
2.2M(+4.3%)$12.3M0.0%+98.32%
29
Increased
995,371(+26.4%)$5.5M0.0%+98.85%
33
New
910,740$5M0.0%+101.38%
37
Increased
415,671(+486.1%)$2.3M0.0%+100.83%
42
Increased
307,790(+120.6%)$1.7M0.0%+93.03%
41
Increased
287,090(+27.2%)$1.6M0.0%-61.41%
32
Decreased
223,177(-31.6%)$1.2M0.0%-8.90%
0
Increased
199,761(+18.7%)$1.1M0.0%+94.59%
20
New
155,626$855,9430.0%+101.38%
34
Decreased
138,825(-82.6%)$763,5380.0%+98.19%
0
Increased
122,277(+22.5%)$672,5240.0%+86.82%
20
Increased
115,952(+636.3%)$637,7360.0%+96.83%
39
Increased
112,671(+20.8%)$619,6900.0%+96.94%
29
Increased
81,133(+32.3%)$446,2320.0%+99.08%
31
Decreased
76,069(-12.0%)$418,3800.0%+39.82%
0
Increased
72,942(+23.5%)$401,1810.0%+65.16%
20
Decreased
64,462(-3.2%)$354,5410.0%+98.19%
0
New
43,848$241,1640.0%+101.38%
32
New
40,552$223,0350.0%+101.38%
32
New
39,752$218,6360.0%+101.38%
35

Showing 1-20 of 56

1 / 3

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used